Skip to main content
Log in

Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The effects of pre-treatment with ENA-713, an acetylcholinesterase (AChE) inhibitor, on changes in pre- and postsynaptic cholinergic indices in gerbil brain following transient ischemia were studied at 4 and 14 days after recirculation. In the ischemic group, hippocampal acetylcholine (ACh) level was significantly reduced (to 23% of sham-operated controls) at 4 days post-ischemia, but this reduction was completely prevented by ENA-713 treatment. Choline acetyltransferase (ChAT) and cholinesterase (ChE) activities were not significantly changed at 4 and 14 days post-ischemia. Although the maximum number (Bmax) of muscarinic ACh receptor (mACh-R) binding in the hippocampus was decreased (to 44%) without any change in affinity at 14 days post-ischemia, this decrease was also inhibited by ENA-713 treatment. In addition, histological experiment indicated that ENA-713 inhibited ischemia-induced pyramidal cell loss in the hippocampal CA1 regions. Thus, these findings suggest that ENA-713 has protective, neurotrophic and therapeutic effects on cerebrovascular type dementia due to cerebral ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Whitehouse, P. J. 1987. Neurotransmitter receptor alterations in Alzheimer disease: A review. Alzheimer disease and associated disorders 1:9–18.

    Google Scholar 

  2. Thal, L. J., Masur, D. M., Fuld, P. A., Sharpless, N. S., and Davies, P. 1983. Memory improvement with oral physostigmine and lecithin in Alzheimer's disease. Biological Aspects of Alzheimer's Disease. Banbury Rep 15:461–469.

    Google Scholar 

  3. Bartus, R. T., Dean, R. L., Beer, B., and Lippa, A. S. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417.

    Google Scholar 

  4. Davis, K. L., and Mohs, R. C. 1982. Enhancement of memory processes in Alzheimer type with multiple dose intravenous physostigmine. Am. J. Psychiat. 139:1421–1424.

    Google Scholar 

  5. Traft, W. C., Clifton, G. L., Blair, R. E., and Edlorenzo, R. J. 1989. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res. 483:143–148.

    Google Scholar 

  6. Nilson, B., and Ponten, U. 1977. Experimental head injury in the rat. Part 2: regional brain energy metabolism in concussive trauma. J. Neurosurg. 47:252–261.

    Google Scholar 

  7. Bes, A., Jauzac, P., Guell, A., Broak, L., and Gerand, G. 1978. Hemodynamic and metabolic factors in human cerebral ischemia. Eur. Neurol. suppl. 1, 17:17–26.

    Google Scholar 

  8. Asplund, K., Hagg, E., Helmers, C., Lithner, F., Strand, T., and Wester, P. O. 1980. The natural history of stroke in diabetic patients. Acta Med. Scand. 207:417–424.

    Google Scholar 

  9. Pulsinelli, W. A., Levy, D. E., Sigsbee, B., Scherer, P., and Plum, F. 1983. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am. J. Med. 74:540–544.

    Google Scholar 

  10. Francis, A., and Pulsinelli, W. 1982. The response of GABAergic and cholinergic neurons to transient cerebral ischemia. Brain Res. 243:271–278.

    Google Scholar 

  11. Kirino, T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:57–69.

    Google Scholar 

  12. Pulsinelli, W. A., Brierley, J. B., and Plum, F. 1982. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:491–498.

    Google Scholar 

  13. Haba, K., Ogawa, N., Mizukawa, K., and Mori, A. 1991. Time course of changes in lipid peroxidation, pre- and postsynaptic cholinergic indices, NMDA receptor binding and neuronal death in the gerbil hippocampus following transient ischemia. Brain Res. 540:116–122.

    Google Scholar 

  14. Enz, A., Amstutz, R., Hofmann, A., Gmelin, G., and Kelly, P. H. 1989. Pharmacological properties of the preferentially centrally acting acetylcholinesterase inhibitor SDZ ENA 713. 271–277, in Kewitz, Thomsen and Bickel, Pharmacological Interventions on Central Cholinergic Mechanisms in Senile Dementia (Alzheimer's Disease), W. Zuchschwerdt Verlag, Munchen.

    Google Scholar 

  15. Tanaka, K., Ogawa, N., Asanuma, M., Hirata, H., Kondo, Y., Nakayama, N., and Mori, A. in press. Effects of the acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain. Arch. Int. Pharmacodyn.

  16. Gibson, G. E., and Duffy, T. E. 1981. impaired synthesis of acetylcholine by mild hypoxic hypoxia or nitrous oxide. J. Neurochem. 36:28–33.

    Google Scholar 

  17. Ogawa, N., Haba, K., Yoshikawa, H., Ono, T., and Mizukawa, K. 1988. Comparison of the effects of bifemelane hydrochloride on ischemia-induced depletion of brain acetylcholine levels in gerbils. Res. Commun. Chem. Pathol. Pharmacol. 61:285–288.

    Google Scholar 

  18. Glowinski, J., and Iversen, L. 1966. Regional studies of catecholamines in the rat brain I. J. Neurochem. 13:655–669.

    Google Scholar 

  19. Fujimori, K., and Yamamoto, K. 1987. Determination of acetylcholine and choline in perchlorate extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J. Chromatogr. 414:167–173.

    Google Scholar 

  20. Haba, K., Ogawa, N., Kawata, M., and Mori, A. 1988. A method for parallel determination of choline acetyltransferase and muscarinic cholinergic receptors: application in aged-rat brain. Neurochem. Res. 13:951–955.

    Google Scholar 

  21. Rappaport, F., Fischi, J., and Pinto, N. 1959. An improved method for the estimation of cholinesterase activity in serum. Clin Chim Acta 4:227–230.

    Google Scholar 

  22. Ogawa, N., Mizuno, S., Nukina, I., Tsukamoto, S., and Mori, A. 1983. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS. Brain Res. 263:348–350.

    Google Scholar 

  23. Kogure, K., Scheinberg, P., Matsumoto, A., Busto, R., and Reinmuth, O. M. 1975. Catecholamines in experimental brain ischemia. Arch. Neurol. 32:21–24.

    Google Scholar 

  24. Ogawa, N., Haba, K., Asanuma, M., Mizukawa, K., and Mori, A. 1991. Super-delayed changes of muscarinic acetylcholine receptor in the gerbil hippocampus following transient ischemia. Adv. Exp. Med. Biol. 287:343–347.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, K., Ogawa, N., Mizukawa, K. et al. Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia. Neurochem Res 19, 117–122 (1994). https://doi.org/10.1007/BF00966804

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00966804

Key Words

Navigation